Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey J Lindeman

Showing results (101-110 of 167) with videos related to

Pageof 17
Sort By:
Breast Cancer Research : BCR|June 18, 2015
Integration of microRNA signatures of distinct mammary epithelial cell types with their gene expression and epigenetic portraitsBhupinder Pal, Yunshun Chen, Andrew Bert, et al.
The Journal of Biological Chemistry|April 16, 2004
Dimerization of CtIP, a BRCA1- and CtBP-interacting protein, is mediated by an N-terminal coiled-coil motifManu J Dubin, Philippa H Stokes, Eleanor Y M Sum, et al.
British Journal of Cancer|January 19, 2019
Phase 1 trial of olaparib and oral cyclophosphamide in BRCA breast cancer, recurrent BRCA ovarian cancer, non-BRCA triple-negative breast cancer, and non-BRCA ovarian cancerChee Khoon Lee, Clare Scott, Geoffrey J Lindeman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 28, 2007
Cancer risk management practices of noncarriers within BRCA1/2 mutation positive families in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast CancerSarah-Jane Dawson, Melanie A Price, Mark A Jenkins, et al.
British Journal of Cancer|May 13, 2020
Predictors of long-term cancer-related distress among female BRCA1 and BRCA2 mutation carriers without a cancer diagnosis: an international analysisKelly A Metcalfe, Melanie A Price, Carol Mansfield, et al.
Familial Cancer|June 14, 2005
Predictors of participation in clinical and psychosocial follow-up of the kConFab breast cancer family cohortKelly-Anne Phillips, Phyllis N Butow, Ailsa E Stewart, et al.
Nature Cell Biology|December 26, 2006
Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiationMarie-Liesse Asselin-Labat, Kate D Sutherland, Holly Barker, et al.
Breast Cancer Research : BCR|June 30, 2021
Single cell transcriptome atlas of mouse mammary epithelial cells across developmentBhupinder Pal, Yunshun Chen, Michael J G Milevskiy, et al.
Breast Cancer Research and Treatment|June 8, 2019
Iniparib administered weekly or twice-weekly in combination with gemcitabine/carboplatin in patients with metastatic triple-negative breast cancer: a phase II randomized open-label study with pharmacokineticsVéronique Diéras, Hervé Bonnefoi, Emilio Alba, et al.
Cancer Cell|July 13, 2013
Targeting BCL-2 with the BH3 mimetic ABT-199 in estrogen receptor-positive breast cancerFrançois Vaillant, Delphine Merino, Lily Lee, et al.
Pageof 17

Showing results (101-110 of 167) with videos related to

Sort By:
Pageof 17
Breast Cancer Research : BCR|June 18, 2015
Integration of microRNA signatures of distinct mammary epithelial cell types with their gene expression and epigenetic portraitsBhupinder Pal, Yunshun Chen, Andrew Bert, et al.
The Journal of Biological Chemistry|April 16, 2004
Dimerization of CtIP, a BRCA1- and CtBP-interacting protein, is mediated by an N-terminal coiled-coil motifManu J Dubin, Philippa H Stokes, Eleanor Y M Sum, et al.
British Journal of Cancer|January 19, 2019
Phase 1 trial of olaparib and oral cyclophosphamide in BRCA breast cancer, recurrent BRCA ovarian cancer, non-BRCA triple-negative breast cancer, and non-BRCA ovarian cancerChee Khoon Lee, Clare Scott, Geoffrey J Lindeman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 28, 2007
Cancer risk management practices of noncarriers within BRCA1/2 mutation positive families in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast CancerSarah-Jane Dawson, Melanie A Price, Mark A Jenkins, et al.
British Journal of Cancer|May 13, 2020
Predictors of long-term cancer-related distress among female BRCA1 and BRCA2 mutation carriers without a cancer diagnosis: an international analysisKelly A Metcalfe, Melanie A Price, Carol Mansfield, et al.
Familial Cancer|June 14, 2005
Predictors of participation in clinical and psychosocial follow-up of the kConFab breast cancer family cohortKelly-Anne Phillips, Phyllis N Butow, Ailsa E Stewart, et al.
Nature Cell Biology|December 26, 2006
Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiationMarie-Liesse Asselin-Labat, Kate D Sutherland, Holly Barker, et al.
Breast Cancer Research : BCR|June 30, 2021
Single cell transcriptome atlas of mouse mammary epithelial cells across developmentBhupinder Pal, Yunshun Chen, Michael J G Milevskiy, et al.
Breast Cancer Research and Treatment|June 8, 2019
Iniparib administered weekly or twice-weekly in combination with gemcitabine/carboplatin in patients with metastatic triple-negative breast cancer: a phase II randomized open-label study with pharmacokineticsVéronique Diéras, Hervé Bonnefoi, Emilio Alba, et al.
Cancer Cell|July 13, 2013
Targeting BCL-2 with the BH3 mimetic ABT-199 in estrogen receptor-positive breast cancerFrançois Vaillant, Delphine Merino, Lily Lee, et al.
Pageof 17